4004:TADAWULDallah Healthcare Co. Analysis

The moving-average structure behind Resonac Holdings Corporation is bullish at ¥15,450.00, with short-term averages leading the long-term ones. The last 30 days have gained 1.3%. RSI sits at 46.6, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at ¥15,005.00 and resistance at ¥18,010.00.
Valuation screens as fair, on a P/E of 52.9 with no clean sector comparison available. The average analyst target implies 36.4% above today's level. Revenue is growing at 15.0% on a 4.2% profit margin. The 0.42% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 80.0%, a beta of 1.46 and a maximum drawdown of 37.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.